INTRODUCTION
Qingkailing (QKL) is a famous herbal compound prescription in China, which consists of Radix isatidis, Flos lonicerae, Fructus gardeniae, Bubali cornu, Concha margaritifera, baicalin, cholic acid and hyodeoxycholic acid. QKL injection is widely used clinically for the treatment of cerebrovascular ischemic disease, ardent fever, hepatitis, pneumonia, H1N1, and avian influenza. However, with the increase of ADR cases reported these years [1] , capsule is favored by more and more patients and doctors in China. There are two marketed forms of QKL capsules in China, hard and soft capsule, with annual sales exceeding RMB 1 billion (US$ 0.15 billion) in 2016.
A previous study has shown that the bioavailability of baicalin in soft capsule is higher than that of hard capsule [2] . Compared with hard capsule, soft capsule had a longer mean residence time (MRT), a higher maximum concentration (C max ), and a larger area under the curve (AUC). The improvement may be caused by the dosage form. Soft capsule may be more beneficial to the stability of the active ingredients both in vitro and in vivo. The drug dissolution behavior may also affect the pharmacokinetic behavior in vivo.
Therefore, the purpose of this study was to evaluate the stability and the drug dissolution behavior of the two capsules by long-term stability testing and semi-bionic incubation experiments. The fingerprint data were processed by principal component analysis (PCA) using SIMCA-P 11.5 software (Umetrics AB, Sweden).
EXPERIMENTAL Materials and processing software

Evaluation of long-term stability of soft and hard capsules
The soft/hard capsules were placed for 0, 1, 2, 3, 6 month as stated in Chinese Pharmacopoeia. The test was carried out at the beginning of each month. Three key ingredients (chlorogenic acid, geniposide and baicalin) were determined according to the method established.
Pretreatment of QKL soft capsules
Oily content (0.4 g) of QKL soft capsules was absorbed by diatomite (1.2 g) and the mixture was transferred into a flask (25 ml) and solvent (acetonitrile: 0.08 % phosphoric acid, 39:61) was added in to volume. The flask was then weighted accurately followed by ultrasonic extraction (200 w, 49 kHz, 70 min). After that, the same solvent was added in to make up the solvent loss caused by ultrasonic extraction. A portion of this solution was centrifugated for 10 min (10,000 rpm). Then pass the supernatant through a filter having a 0.45-μm porosity, and use the filtrate after discarding the first 2 ml. Two samples were prepared by the same method at a time.
Pretreatment of QKL hard capsules
Transfer an accurately weighed portion of the powder (0.5 g) of hard capsules to a 25-ml flask, solvent (acetonitrile: 0.08 % phosphoric acid, 39:61) was added in to volume. The flask was weighted accurately followed by ultrasonic extraction, the remaining steps were the same as soft capsule group. Two samples were prepared by the same method at a time.
Fingerprint analysis
The fingerprint of the two capsules was studied according to the Technical Requirements of Fingerprint Research on Traditional Chinese Medicine Injection [4] , which is made by CFDA. Baicalin, the highest peak, was chosen as the reference peak. The precision, stability and repeatability were studied and were all met the requirements of the guidance.
Drug dissolution studies by semi-bionic incubation methods
Simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) were prepared according to Chinese Pharmacopoeia [5] . Preparation of gastric lavage fluid: Rats fasted 24 h with free access to water. They were anaesthetized by 20 % urethanes (2 ml) and placed on a hot pad to maintain normal body temperature. An abdominal midline incision was made. Then semi-circular incisions were made at the ends of stomach. PE tubes were inserted into cardia and pylori respectively and then ligated with silk sutures. Stomach was lavaged with 15 ml SGF (37 o C). The lavage fluid of 3 rats (about 40 ml) was collected into a 50 ml flask and then dilute with SGF to volume, and mix.
Preparation of intestinal lavage fluid: Rats were anaesthetized and were celiotomized. Semicircular incisions were made at the fore-end of duodenum and back-end of ileum. PE tubes were inserted in and ligated with silk sutures. Small intestine was lavaged with 40 ml SIF (37 ℃). The lavage fluid was collected into a 50 ml flask and then dilute with SIF to volume, and mix.
Drug dissolution in gastric lavage fluid: Place 50 ml gastric lavage fluid in a triangular flask, equilibrate the dissolution medium to 37 ℃ in a constant temperature shaker. Place QKL soft capsule (or hard capsule) in the triangular flask. At each of the test-time points (1, 5, 10, 30, 60, 90,120 and 240 min), withdraw a specimen (1 ml) from the triangular flask. And replace the aliquots withdrawn for analysis with equal volumes of fresh dissolution medium at 37 o C. Sodium hydroxide solution (0.1 mol/l, 400 μl) was added into the withdrawn as the neutralizer. Then, add 2 ml of methanol to precipitate the pepsin.
The mixture was vortexed for 3 min and then centrifuged for 10 min (10,000 rpm). Pass the supernatant through a filter having a 0.22-μm porosity, and use the filtrate after discarding the first 0.5 ml as the test solution. Inject 20 μl test solution into the chromatograph, record the chromatograms, and measure the peak responses. Six dosage units were tested by the same method at a time. The amount of dissolved drug Q (expressed as a percentage of the labeled content of the dosage unit) was calculated according to Eq 1.
where C n is the drug concentration of the nth time point (mg/ml); C i is the drug concentration in flask of the ith (i ≤ n-1) sampling point; D is the content of the dosage unit.
Drug dissolution in intestinal lavage fluid: Both hard capsule and soft capsule broke in the gastric lavage fluid in a few minutes. In this study, the contents of capsules (instead of capsules) were incubated with intestinal lavage fluid (50 ml). The test-time points were 0.083, 0.25, 0.5, 1, 1.5, 2, 4, 6, 8, 12, 18, 24 h. At each of the time stated, withdraw a specimen (1 ml) from the triangular flask. Then, add 2 ml of methanol to precipitate trypsin, the remaining steps were the same as gastric lavage fluid group. The amount of dissolved drug Q was calculated according to Eq 2.
where C n is drug concentration of the nth time point (mg/ml); C i is the drug concentration in flask of the ith (i ≤ n-1) sampling point; D is the content of the dosage unit.
The linearity, precision, stability, repeatability and recovery of chlorogenic acid, geniposide, baicalin were studied according to General Requirements of Chinese Pharmacopoeia [5] . The fingerprint methodology was studied according to Technical Requirements of Fingerprint Research on Traditional Chinese Medicine Injection [4] . And they all met the requirements.
Chromatographic conditions
The separation conditions were carried out on a Phenomenex Luna RP18 column (250 × 4.6 mm i.d., 5 μm), the temperature was set at 30 ℃. The flow rate was set at 1.0 ml/min. A DAD detector was used for detection, and the wavelength was set at 327 nm (for chlorogenic acid), 240 nm (for geniposide), 278 nm (for baicalin), 254 nm (for fingerprint).
Data analysis
The contents of three key ingredients were calculated according to the peak responses of standards and samples. Data of soft capsule and hard capsule groups were analyzed by Student's test with p < 0.05 set as statistically different.
Fingerprint data of different capsules or different sampling time points were imported to SIMCA-P (version 11.5) software and were processed by principal component analysis (PCA). It is a wellknown chemometric method for the decomposition of two-dimensional matrices. Loading Bi Plots can be offered by the software without manual calculation.
RESULTS
Long-term stability comparison between soft and hard capsules based on multi-component quantification
The contents of chlorogenic acid, geniposide and baicalin in hard capsule and soft capsule were determined. The contents of three key ingredients remained were shown in Figure 1 . As was shown in the picture, these key ingredients degraded slowly in the past 6 months in both soft and hard capsules, but they all remained > 90 %. No differences were observed (p > 0.05). 
Long-term stability of soft and hard capsules based on fingerprint pattern analysis
There are many other ingredients in this herbal compound prescription. There were 21 common peaks (their peak areas account for 87.42 % of all peaks areas) and 16 common peaks (their peak areas account for 84.59 % of all peaks areas) were identified in soft and hard capsules samples (11 batches for each capsule), respectively.
PCA was used to evaluate the stability of two capsules integrally. Fingerprint data of QKL soft/hard capsules were imported in software SIMCA-P 11.5. And PC1 could explain nearly 100 % of variance. The PCA scatter plot (PC1 versus PC2) was shown in Fig 2. The samples of soft capsules of 0, 1, 2, 3, 6 month (two samples for each time point) were clustered together. But, the samples of hard capsules were clearly divided into two groups, which indicated that samples of 6 month were quite different from the other samples of hard capsule.
Drug dissolution of QKL soft and hard capsules in gastric lavage fluid
QKL soft and hard capsules ruptured in no more than 15 minutes and 1 minute, respectively. As was shown in Figure 3 , for hard capsule, not less than 50 % (Q) of the chlorogenic acid and geniposide were dissolved in 15 min, and they kept growing in the next 225 min. But the Q of baicalin decreased after a fast dissolution in the first 15 min.
For soft capsule group, the Q of three ingredients kept growing in 240 min, and finally reached 7.32 % (chlorogenic acid), 13.64 % (geniposide), 1.02 % (baicalin). 
Drug dissolution of QKL soft and hard capsules in intestinal lavage fluid
Compared with gastric lavage fluid group, different dissolution behavior was observed in intestinal lavage fluid. As was shown in Figure 4 , for hard capsule, not less than 90 % of chlorogenic acid, geniposide and baicalin were dissolved in 2 h. Then, they all declined gently (to about 80 %).
However, for soft capsule, whose dissolution behavior is quite different, the Q of 3 ingredients kept growing up to 95.18 % (chlorogenic acid), 93.18 % (geniposide), 99.31 % (baicalin) in 12 h. And they were stable in the following 12 h (with a variation of less than 3 %). 
Drug dissolution of QKL soft capsules in intestinal lavage fluid based on fingerprint pattern analysis
As shown in Figure 3 and Figure 4 , the key ingredients were unstable when hard capsules were incubated with gastric lavage fluid and intestinal lavage fluid. The degradation may affect the analysis based on fingerprint pattern statistical analysis. However, soft capsule can keep the ingredients stable in intestinal lavage fluid, the Q of 3 ingredients were kept at about 95 % finally. So, drug dissolution behavior of soft capsule in intestinal lavage fluid based on fingerprint pattern analysis was studied.
PCA was also used to evaluate the drug dissolution behavior of soft capsules integrally. Fingerprint data of QKL soft capsules were imported in software (six samples for each time point).
For soft capsules, three principal components affecting the dissolution behavior were identified with a cumulative score 43.7 %. The loading Bi Plot (PC1 versus PC2) was shown in Figure 5 . Chromatogram peaks (△) close to the time points (■) contribute the most to the differentiation of the samples of different sampling time, which indicated that, for soft capsule, peak 11 
DISCUSSION
The key ingredients of QKL soft/hard capsules had good stability in vitro within 6 months. The contents of chlorogenic acid, geniposide and baicalin remained > 90 %.
Saline, SGF or SIF are commonly used as the mediums in drug dissolution studies. However, besides pepsin and trypsin, there are many kinds of enzymes and intrinsic factors in stomach and small intestine, which may also affect the metabolism of drugs. In this study, we prepared gastric lavage fluid and intestinal lavage fluid as the mediums of drug dissolution.
In gastric lavage fluid, for hard capsule, three key ingredients dissolved quickly. But baicalin degraded after 15 minutes, which might be caused by pepsin and pH of the environment [6]. For soft capsule, the Q of three ingredients kept growing in the whole sampling time.
In intestinal lavage fluid, for hard capsule, the Q of 3 key ingredients reached 90 % in 2 hours. But then, they all decreased to about 80 %. For soft capsule, sustained release behaviors were observed in 12 hours and the Q of three ingredients has been maintained. The oily accessories may protect the ingredients from degradation caused by enzymes, and OH -. Besides, the sustained release of the drug may also increase the bioavailability, in previous study [2] .
Compared with chemical drug, traditional Chinese medicine (or herbal medicine) is characteristic of multi-component with multitarget, which brings a great challenge for quality control [7] . Usually, some components are chosen as indicators for quality control, however, they can hardly express the information of the preparation fully. Pattern recognition analysis in combination with fingerprint can provide a visual, simple and valid method for quality control of traditional Chinese medicine [8] . Integrated evaluation based on pattern recognition analysis can achieve a comprehensive analysis for multidimensional information of traditional Chinese medicine and has been used on study of Chinese material medica [9, 10] , like producing area [11] , taxa of medicinal plant [12] and quality control of traditional Chinese medicine injections [13] .
PCA (Principal Component Analysis) is a method of multivariate statistical analysis for integrated evaluation. A collection of observations of possibly correlated variables are transformed in to a set of values of linear uncorrelated variables (usually, the number of these new variables is less than that of the original variables), which were considered as principle components. The first principal component could explain as much of the variability in the data as possible. Each subsequent component also has the highest variance with the constraint that it is orthogonal to the preceding components. Finally, an orthogonal basis set with uncorrelated vectors was obtained.
Consider a data matrix, X, its rows is fulfilled with peak areas of chromatography at different time, its columns is described by different samples. For example, Eq 1 is our original observation matrix:
In this matrix, m random variables form a vector of m dimensions. That is, . Its mean vector is denoted by , its covariance is denoted by . Consider the following linear transformation:
……… (4) It can be written as the product of matrix:
…………………. (5) where , and
…………… (6) As mentioned above, PCA is considered as a linear transformation method which can transform original data to a new coordinate system. The greatest variance by some projection of the data comes to lie on the first coordinate (called the first principal component), the second greatest variance on the second coordinate, and so on [14]. Thus we know that the problem to obtain the principal component is to find a linear function of variable such that the variance of could be as large as possible. That is, we need …………. (7) reach its maximal value. And we have two constraint conditions. First, we need ……….. (8) to avoid .
Second, we want each of principal components are uncorrelated. We need ……. (9) Under these constraint conditions, we know that principal components achieve their maximal value when is the eigenvector of  and the eigenvalue of  is the variance of principal components.
Assume there are m eigenvalues of :
, and denotes corresponding normalized orthogonal eigenvectors. Its matrix have the form: ………….
(10)
Then the ith principal component is given by the following:
……. (11) After getting the principal components, we can do some cluster analysis of our samples. Observe the crucial samples of each principal component, If and have superior contribution rate for , and their contribution rate are close, we could conclude that they should be clustered. The computing process can be conducted by software SIMCA-P.
In our study of long-term stability, samples of soft capsules of different month were clustered together. Meanwhile, the samples of hard capsules were divided into two cluster, the samples of 6 th month are far from the other samples, which indicates that the fingerprint of hard capsule has changed a lot in 6 th month. To some extent, soft capsule is more stable than hard capsule.
In the study of drug dissolution evaluation, samples of different time were taken as the columns of the matrix. To understand which components contributed to the differentiation, a Loading Bi-plot, which presented all key items (samples of different time and chemical components represented by different peaks) in one picture to demonstrate the relationships among them, was investigated. In this plot, samples (represented by diamonds) in close proximity to components (represented by triangles) have high levels of these component, and the components away from the sample symbols are low in these samples.
In general, the proximity between the sample symbols and component symbols indicates their correlation. Therefore, this Bi-plot showed that most of the components (peaks) are positively correlated with the samples from 6 h to 24 h, which indicated the sustained release behavior of the soft capsule. For soft capsule, an O/W emulsion may be formed by the protein in intestinal lavage fluid with gently shaking. The indicators (chlorogenic acid, geniposide and baicalin) dispersed in the oily accessories were kept stable and the other components were released slowly. Previous study showed that the bioavailability of baicalin in soft capsule is higher than that of hard capsule, which may be also caused by the protection and absorption enhancement of emulsion.
CONCLUSION
QKL soft capsule displayed better stability than the hard capsule both in vitro and in semi-bionic condition. The soft capsule also displayed sustained release behavior, and thus, may also have a superior therapeutic effect. 
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